Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis

Neuro-Oncology

Volumn 6, Issue 3, 2004, Pages 227-235

  Lamborn, Kathleen R ^a   Chang, Susan M ^a   Prados, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CARMUSTINE; EFLORNITHINE; FLUOROURACIL; HYDROXYUREA; LOMUSTINE; MISONIDAZOLE; PROCARBAZINE; TEMOZOLOMIDE; THALIDOMIDE; TIOGUANINE; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; GLIOBLASTOMA; HIGH RISK PATIENT; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ADULT; AGED; BRACHYTHERAPY; BRAIN NEOPLASMS; CLINICAL TRIALS; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; FORECASTING; GLIOBLASTOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 4344594951     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1152851703000620     Document Type: Article

References (8)

1. Breiman, L., Friedman, J.H., Olshen, R.A., and Stone, C.J. (1984) Classification and Regression Trees. Belmont, Calif.: Wadsworth International Group.
2. Curran, W.J., Jr., Scott, C.B., Horton, J., Nelson, J.S., Weinstein, A.S., Fischbach, A.J., Chang, C.H., Rotman, M., Asbell, S.O., Krisch, R.E., and Nelson, D.F. (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J. Natl. Cancer Inst. 85, 704-710.
3. GMT. Glioma Meta-analysis Trialists (GMT) Group (2002) Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359, 1011-1018.
4. Keles, S., and Segal, M.R. (2002) Residual-based tree-structured survival analysis. Stat. Med. 21, 313-326.
5. Laperriere, N.J., Leung, P.M.K., McKenzie, S., Milosevic, M., Wong, S., Glen, J., Pintilie, M., and Bernstein, M. (1998) Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int. J. Radiat Oncol. Biol. Phys. 41, 1005-1011.
6. Schmoor, C., Ulm, K., and Schumacher, M. (1993) Comparison of the Cox model and the regression tree procedure in analysing a randomized clinical trial. Stat. Med. 12, 2351-2366.
7. Selker, R.G., Shapiro, W.R., Burger, P., Blackwood, M.S., Deutsch, M., Arena, V.C., Van Gilder, J.C., Wu, J., Malkin, M.G., Mealey, J., Jr., Neal, J.H., Olson, J., Robertson, J.T., Barnett, G.H., Bloomfield, S., Albright, R., Hochberg, F.H., Hiesiger, E., Green S., and Brain Tumor Cooperative Group (2002) The Brain Tumor Cooperative Group NIH trial 87-01: A randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51, 343-357.
8. Therneau, T.M., Grambsch, P.M., and Fleming, T.R. (1990) Martingale-based residuals for survival models. Biometrika 77, 147-160.